These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16121683)

  • 1. Antibacterial agents: patent highlights January 2005 to June 2005.
    Phillips OA
    Curr Opin Investig Drugs; 2005 Aug; 6(8):768-80. PubMed ID: 16121683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibacterial agents: patent highlights January to June 2004.
    Phillips OA
    Curr Opin Investig Drugs; 2004 Aug; 5(8):799-808. PubMed ID: 15600236
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibacterial agents: patent highlights July to December 2002.
    Phillips OA
    Curr Opin Investig Drugs; 2003 Feb; 4(2):117-27. PubMed ID: 12669371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibacterial agents: patent highlights January to June 2002.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2002 Dec; 3(12):1701-11. PubMed ID: 12528302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial agents (oxazolidinones, quinolones, macrolides and new agents): patent highlights June to December 2000.
    Phillips OA; Matowe WC
    Curr Opin Investig Drugs; 2001 Jun; 2(6):745-51. PubMed ID: 11572651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibacterial agents: patent highlights January to June 2003.
    Phillips OA
    Curr Opin Investig Drugs; 2003 Aug; 4(8):926-36. PubMed ID: 14508876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Reactions of derivatives of beta-lactam antibiotics with non-antibacterial biological activity].
    Gunda T
    Acta Pharm Hung; 2002; 72(4):223-30. PubMed ID: 12812042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding the longevity of the beta-lactam antibiotics and of antibiotic/beta-lactamase inhibitor combinations.
    Buynak JD
    Biochem Pharmacol; 2006 Mar; 71(7):930-40. PubMed ID: 16359643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Beta-lactam inhibitors of beta-lactamases in Mycobacterium].
    Galán JC
    Rev Esp Quimioter; 1998 Dec; 11(4):386-8. PubMed ID: 10336326
    [No Abstract]   [Full Text] [Related]  

  • 10. 5,5,6-Fused tricycles bearing imidazole and pyrazole 6-methylidene penems as broad-spectrum inhibitors of beta-lactamases.
    Venkatesan AM; Agarwal A; Abe T; Ushirogochi H; Ado M; Tsuyoshi T; Dos Santos O; Li Z; Francisco G; Lin YI; Petersen PJ; Yang Y; Weiss WJ; Shlaes DM; Mansour TS
    Bioorg Med Chem; 2008 Feb; 16(4):1890-902. PubMed ID: 18061461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The oxazolidinone antibacterial agent DuP 105 does not act on cell wall biosynthesis or on a beta-lactamase.
    Silverman RB; Tran N; Sinha RK; Neuhaus FC
    Biochem Biophys Res Commun; 1993 Sep; 195(2):1077-80. PubMed ID: 8373386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative activity of beta-lactamase inhibitors combined with beta-lactams against antibiotic-resistant enterobacter.
    Tejedor-Junco MT; Gonzalez-Martin M; Lupiola PA; Santana OE; Lopez-Orge RH; Gonzalez-Lama Z
    J Chemother; 1989 Jul; 1(4 Suppl):346-8. PubMed ID: 16312432
    [No Abstract]   [Full Text] [Related]  

  • 13. [Re-evaluation of the gastrointestinal effects of beta-lactam inhibitors of beta-lactamase].
    Sábada B
    Rev Esp Quimioter; 1998 Dec; 11(4):377-9. PubMed ID: 10336322
    [No Abstract]   [Full Text] [Related]  

  • 14. Beta-lactams and beta-lactamase-inhibitors in current- or potential-clinical practice: a comprehensive update.
    Shahid M; Sobia F; Singh A; Malik A; Khan HM; Jonas D; Hawkey PM
    Crit Rev Microbiol; 2009; 35(2):81-108. PubMed ID: 19514910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assays for beta-lactamase activity and inhibition.
    Viswanatha T; Marrone L; Goodfellow V; Dmitrienko GI
    Methods Mol Med; 2008; 142():239-60. PubMed ID: 18437319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 4-Substituted trinems as broad spectrum beta-lactamase inhibitors: structure-based design, synthesis, and biological activity.
    Plantan I; Selic L; Mesar T; Anderluh PS; Oblak M; Prezelj A; Hesse L; Andrejasic M; Vilar M; Turk D; Kocijan A; Prevec T; Vilfan G; Kocjan D; Copar A; Urleb U; Solmajer T
    J Med Chem; 2007 Aug; 50(17):4113-21. PubMed ID: 17665896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide deformylase--a promising therapeutic target for tuberculosis and antibacterial drug discovery.
    Sharma A; Khuller GK; Sharma S
    Expert Opin Ther Targets; 2009 Jul; 13(7):753-65. PubMed ID: 19530983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of some beta-lactams in combination with dicloxacillin against Mycobacterium fortuitum.
    Fattorini L; Amicosante G; Fiorentino D; Franceschini N; Oratore A; Orefici G
    J Chemother; 1989 Jul; 1(4 Suppl):339-41. PubMed ID: 16312429
    [No Abstract]   [Full Text] [Related]  

  • 19. New antibacterial agents: patent applications published in 2010.
    Stokes SS; Morningstar M; Kocis H; Verheijen JC
    Pharm Pat Anal; 2012 Nov; 1(5):601-20. PubMed ID: 24236928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of beta-lactam and non-beta-lactam antibiotics in extended-spectrum beta-lactamase-producing clinical isolates of Escherichia coli.
    Puerto AS; Fernández JG; del Castillo Jde D; Pino MJ; Angulo GP
    Diagn Microbiol Infect Dis; 2006 Feb; 54(2):135-9. PubMed ID: 16406187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.